Search

everythinglearnresearchcommunity

for

Search:↓

Quercetin may help with PCOS symptoms, but more research is needed.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Minoxidil and ATRA together boost hair growth more effectively than minoxidil alone.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

Long-term fluticasone treatment does not harm the immune system in horses with heaves.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Sex hormones affect brain injury differently in males and females.

Mice without certain skin proteins had abnormal skin and hair development.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Steroids, particularly estrogens and 5α-reductase inhibitors, affect blood vessel-related hair growth processes in hair follicle cells.

The 3D scaffold helped maintain hair cell traits and could improve hair loss treatments.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Adult stem cells are important for tissue repair and have therapeutic potential, but more research is needed to fully use them.

Finasteride reduces alcohol withdrawal effects, especially in female mice.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.